Dr Mark K Yamanaka, MD in Oceanside, CA - Medicare Pulmonary Disease

Dr Mark K Yamanaka, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Oceanside, California. He went to University Of California, Davis School Of Medicine and graduated in 1981 and has 43 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Cep America - Intensivists Pc, Pulmonary Specialists Of North County Inc and his current practice location is 3907 Waring Rd Ste 2, Oceanside, California. You can reach out to his office (for appointments etc.) via phone at (760) 941-0221.

Dr Mark K Yamanaka is licensed to practice in California (license number G48542) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013004852.

Contact Information

	Dr Mark K Yamanaka, MD
	3907 Waring Rd Ste 2, Oceanside, CA 92056-4454
	(760) 941-0221
	(760) 941-0905

Physician's Profile

Full Name	Dr Mark K Yamanaka
Gender	Male
Speciality	Pulmonary Disease
Experience	43 Years
Location	3907 Waring Rd Ste 2, Oceanside, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Mark K Yamanaka attended and graduated from University Of California, Davis School Of Medicine in 1981

NPI Data:

NPI Number: 1013004852
Provider Enumeration Date: 10/05/2006
Last Update Date: 07/12/2023

Medicare PECOS Information:

PECOS PAC ID: 6305977299
Enrollment ID: I20100621000523

Medical Identifiers

Medical identifiers for Dr Mark K Yamanaka such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013004852	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0200X	Internal Medicine - Critical Care Medicine	G48542 (California)	Secondary
207RP1001X	Internal Medicine - Pulmonary Disease	G48542 (California)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Tri-city Medical Center	Oceanside, CA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Cep America - Intensivists Pc	9032423421	48
Pulmonary Specialists Of North County Inc	0042624223	4

News Archive

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

Using a growth factor to stimulate production of circulating endothelial progenitor cells increases the numbers of these vascular regenerative cells, improves mobility, and potentially could improve blood vessel function in patients with peripheral arterial disease (PAD).

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

BioScrip®, Inc. today announced 2014 fourth quarter financial results. Fourth quarter revenue from continuing operations was $253.7 million and the net loss from continuing operations was $61.9 million, or $0.90 per basic and diluted share.

Hsp-27 protein: An indicator of prostate cancer progression

In the largest study of its kind, the international team of pathologists studied an initial 4,000 prostate cancer patients over a period of 15 years to further understanding into the natural progression of the disease and how it should be managed. The research, published in the British Journal of Cancer, could be used to develop a blood test to distinguish between aggressive and non-aggressive forms of prostate cancer.

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Researchers are a step closer to understanding why cigarette smoke exposure during pregnancy may increase the risk of sudden infant death syndrome (SIDS).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mark K Yamanaka allows following entities to bill medicare on his behalf.

Entity Name	Cep America - Intensivists Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1407234057 PECOS PAC ID: 9032423421 Enrollment ID: O20150729008559

News Archive

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Researchers are a step closer to understanding why cigarette smoke exposure during pregnancy may increase the risk of sudden infant death syndrome (SIDS).

Entity Name	Pulmonary Specialists Of North County Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073127247 PECOS PAC ID: 0042624223 Enrollment ID: O20210129000675

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Researchers are a step closer to understanding why cigarette smoke exposure during pregnancy may increase the risk of sudden infant death syndrome (SIDS).

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark K Yamanaka is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark K Yamanaka, MD 3907 Waring Rd Ste 2, Oceanside, CA 92056-4454 Ph: (760) 941-0221	Dr Mark K Yamanaka, MD 3907 Waring Rd Ste 2, Oceanside, CA 92056-4454 Ph: (760) 941-0221

News Archive

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Researchers are a step closer to understanding why cigarette smoke exposure during pregnancy may increase the risk of sudden infant death syndrome (SIDS).

Internal Medicine Doctors in Oceanside, CA

Javaid Ahmed Shad, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3923 Waring Rd Ste A, Oceanside, CA 92056 Phone: 760-724-8782 Fax: 760-842-7801
David G. Antoun, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4002 Vista Way, Oceanside, CA 92056 Phone: 760-724-8411
Pratan Vathesatogkit, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3231 Waring Ct, Suite D, Oceanside, CA 92056 Phone: 760-630-4833 Fax: 760-758-1980
Ian B Butler, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3231 Waring Ct Ste D, Oceanside, CA 92056 Phone: 760-941-0221 Fax: 760-941-0905
Dr. Ronald Hansel Main, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3460 Marron Rd Ste 103-477, Oceanside, CA 92056 Phone: 760-681-8160
Dr. Christopher Davis, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 200 Mercy Circle, Oceanside, CA 92055 Phone: 760-725-7410

Dr Mark K Yamanaka, MD - Medicare Pulmonary Disease in Oceanside, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Medicare Reassignments

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Using a growth factor to stimulate production of circulating endothelial progenitor cells improves cell production and mobility in arterial disease

BioScrip's total revenue increases $28.2 million to 2.5% in fourth quarter 2014

Hsp-27 protein: An indicator of prostate cancer progression

Prenatal cigarette smoke exposure and high temperatures linked to increased SIDS risk

Internal Medicine Doctors in Oceanside, CA